Drug intelligence / Profile preview

IONP-TNA@Man

Development stage
Preclinical
Lead developer
National Cheng Kung University
Modality
Nanoparticles → Drug Delivery Systems
01

Overview

IONP-TNA@Man (also known as IONP-TNA@MA) is a d-mannose-modified iron oxide-tannic acid nanoparticle designed for the photothermal treatment of bacterial infections, particularly those caused by extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (E. coli). The nanoparticle is synthesized via a tannic acid (TNA)-assisted hydrothermal reaction that converts iron oxide nanopowder (IONP) into black colloidal Fe3O4 nanoparticles, which are subsequently modified with d-mannose. The d-mannose moiety targets the FimH adhesin on the bacterial membrane, allowing the nanoparticles to adhere specifically to E. coli. Upon exposure to near-infrared (NIR) light (e.g., 808 nm), the nanoparticles exhibit high photon-to-thermal conversion, generating localized heat that destroys the bacteria with minimal cytotoxicity to human urothelial cells.

Other names
Fe3O4@TNA@MAFe3O4@TNA@Mand-mannose-modified iron oxide-tannic acid nanoparticlesiron oxide-tannic acid-mannose nanoparticles

Beyond the preview

Go deeper on IONP-TNA@Man.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IONP-TNA@Man.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call